1. |
Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn’t. BMJ, 1996, 312(7023): 71-72.
|
2. |
张晓雨, 陈诗琪, 李承羽, 等. 循证中医药学理论研究与应用实践. 中国循证医学杂志, 2018, 18(1): 86-91.
|
3. |
The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA, 1994, 272(24): 1926-1931.
|
4. |
Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA, 1996, 276(8): 637-639.
|
5. |
Moher D, Jones A, Lepage L, et al. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA, 2001, 285(15): 1992-1995.
|
6. |
Turner L, Shamseer L, Altman DG, et al. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev, 2012, 1: 60.
|
7. |
Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration (traditional chinese version). Ann Intern Med, 2017, 167(2): W7-W20.
|
8. |
Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med, 2017, 167(2): 112-121.
|
9. |
Cheng CW, Wu TX, Shang HC, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration (simplified Chinese version). Ann Intern Med, 2017, 167(2): W21-W34.
|
10. |
Linde K, Brinkhaus B. Randomized trials of Chinese herbal medicine: a new extension of the CONSORT statement. Ann Intern Med, 2017, 167(2): 133-134.
|
11. |
田然, 赵晨, 郑颂华, 等. 中医药临床疗效研究报告体系构建过程. 中国循证医学杂志, 2018, 18(7): 651-653.
|
12. |
吴泰相, 李幼平, 卞兆祥, 等. 中医药临床随机对照试验报告规范 (征求意见稿). 中国循证医学杂志, 2007, 7(8): 601-605.
|
13. |
吴泰相, 李幼平, 卞兆祥, 等. 中医药临床随机对照试验报告规范 (征求意见稿). 中国循证医学杂志, 2007, 7(9): 625-630.
|
14. |
Available at: http://www.consort-statement.org/about-consort/endorsers1.
|
15. |
原源. 《实用中医内科杂志》2018 作者自检指南 (论著类论文). 实用中医内科杂志, 2018, 32(5): 2.
|
16. |
Cao XJ, Huang X, Liu J, et al. A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine capsules for the treatment of premature ovarian insufficiency. Menopause, 2018, 25(8): 918-926.
|
17. |
Chen S, Xu MB, Zhou XL, et al. Chinese herbal medicine for myasthenia gravis: a systematic review and meta-analysis. Front Pharmacol, 2018, 9: 969.
|
18. |
Kim KI, Jun JH, Baek H, et al. Oral administration of herbal medicines for radiation pneumonitis in lung cancer patients: A systematic review and meta-analysis. PLoS One, 2018, 13(5): e0198015.
|
19. |
Li C, Wang P, Zhang L, et al. Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials. J Ethnopharmacol, 2018, 224: 512-521.
|
20. |
Lin H, Wang X, Du X, et al. Effect of Zhizhu Kuanzhong capsule on functional dyspepsia: Protocol for a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore), 2018, 97(6): e9731.
|
21. |
Lyu YR, Yang WK, Park SJ, et al. Efficacy and safety of GHX02 in the treatment of acute bronchitis: protocol of a phase II, double-blind, randomised placebo-controlled trial. BMJ Open, 2018, 8(5): e019897.
|
22. |
Myers EF, Parrott JS, Splett P, et al. Using risk of bias domains to identify opportunities for improvement in food- and nutrition-related research: An evaluation of research type and design, year of publication, and source of funding. PLoS One, 2018, 13(7): e0197425.
|
23. |
Tabatabaei-Malazy O, Shadman Z, Ejtahed HS, et al. Quality of reporting of randomized controlled trials of herbal medicines conducted in metabolic disorders in Middle East countries: A systematic review. Complement Ther Med, 2018, 38: 61-66.
|
24. |
Wang F, Tang J, Li P, et al. Chloroquine enhances the radiosensitivity of bladder cancer cells by inhibiting autophagy and activating apoptosis. Cell Physiol Biochem, 2018, 45(1): 54-66.
|
25. |
Zhang HP, Wang L, Wang Z, et al. Chinese herbal medicine formula for acute asthma: A multi-center, randomized, double-blind, proof-of-concept trial. Respir Med, 2018, 140: 42-49.
|
26. |
Zhao XM, Zhang Y, He XH, et al. Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial. Trials, 2018, 19(1): 200.
|
27. |
白洋, 车方远, 易文慧, 等. 加载口服中成药对 PCI 术后长期主要不良心脑血管事件影响的 Meta 分析. 中医杂志, 2018, 59(12): 1024-1030.
|
28. |
成舟, 陈丽芳, 谭登, 等. 中药熏洗治疗跟痛症的临床试验质量评价. 中国中医骨伤科杂志, 2018, 26(2): 76-80.
|
29. |
鄢丹, 刘娟, 王爱婷, 等. 基于循证医学证据探讨中医药优势病种作用机制的研究思路. 中国中药杂志, 2018, 43(13): 2633-2638.
|
30. |
于丹丹, 谢雁鸣, 廖星, 等. 《中国中药杂志》发表随机对照试验方法学和报告质量评价研究. 中国中药杂志, 2018, 43(4): 833-839.
|
31. |
原源, 朱民, 苏雨, 等. 格式化表达-老中医经验类论文撰写一般要素探讨. 中医药导报, 2018, 24(13): 130-133.
|
32. |
张俊华, 李幼平, 张伯礼. 循证中医药学:理论与实践. 中国中药杂志, 2018, 18(1): 1-7.
|
33. |
Wu T, Bian Z, Shang H, et al. Innovation of clinical trials in China: Commentary on the publication of "CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration". J Evid Based Med, 2017, 10(3): 155-162.
|
34. |
MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med, 2010, 7(6): e1000261.
|
35. |
MacPherson H, White A, Cummings M, et al. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med, 2001, 9(4): 246-249.
|
36. |
Available at: http://journals.plos.org/plosmedicine/article/metrics?id=10.1371/journal.pmed.1000261.
|
37. |
Macpherson H, Altman DG, Hammerschlag R, et al. 针刺临床试验干预措施报告标准修订版: CONSORT 声明的扩展. 中国循证医学杂志, 2010, 10(10): 1228-1239.
|
38. |
Macpherson H, Altman DG, Hammerschlag R, et al. 针刺临床试验干预措施报告标准的修订: CONSORT 声明的扩展. 中西医结合学报, 2010, 8(9): 804-818.
|
39. |
Available at: http://kns.cnki.net/kns/brief/default_result.aspx.
|
40. |
Available at: https://embase.com/#advancedSearch/resultspage/history.1/page.1/25.items/orderby.date/source.
|
41. |
付姝菲, 郑颂华, 张莉, 等. Consensus-based recommendations for case report in Chinese medicine(CARC). 中国结合医学杂志 (英文版), 2016, (1): 73-79.
|
42. |
Kim J, Eom YJ, Lee YS, et al. The current status of quality of reporting in acupuncture treatment case reports: an analysis of the core journal in Korea. Evid Based Complement Alternat Med, 2017, 2017: 5810372.
|
43. |
Zhao C, Liu Z, Lin J, et al. Standardizing individualized efficacy evaluation to optimize evidence-using pattern in traditional chinese medicine-preliminarily establishing traditional Chinese medicine evidence-based case reporting system. World J Trad Chin Med, 2016, 2(4): 49-54.
|
44. |
Fu SF, Kun W, Zeng XX, et al. Urgent need to improve the quality of case report in traditional Chinese medicine: assessment on reporting quality of 3417 cases. Chin J Integ Med, 2016, 22(6): 473-480.
|
45. |
Wang Y. Improving general evaluation of clinical consensus statement in chinese medicine by integrating chinese and western medicine and multidisciplinary approaches. J Evid Based Med, 2016, 9(3): 109-111.
|
46. |
Available at: http://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines- under-development-for-systematic-reviews/#65.
|
47. |
刘建平, 张玫, 杨闵, 等. 单病例随机对照试验设计在中医药研究中的应用. 中国中医药信息杂志, 2002, 9(6): 66-68.
|
48. |
Vohra S, Shamseer L, Sampson M, et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. BMJ, 2015, 350: h1738.
|
49. |
向玉, 温泽淮. 临床实践中推拿手法规范化的思考. 中华中医药杂志, 2018, 33(6): 2455-2458.
|
50. |
Boutron I, Altman DG, Moher D, et al. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med, 2017, 167(1): 40-47.
|
51. |
Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 声明: 定义临床研究方案的标准条目. 中国循证医学杂志, 2013, 13(12): 1501-1507.
|
52. |
Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med, 2013, 158(3): 200-207.
|
53. |
Chen Y, Yang K, Marušic A, et al. A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement. Ann Intern Med, 2017, 166(2): 128-132.
|
54. |
Chen Y, Wang C, Shang H, et al. Clinical practice guidelines in China. BMJ, 2018, 360: j5158.
|
55. |
Available at: http://www.who.int/ictrp/trial_reg/en/.
|